Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection

In conclusion, biochanin A protected the host from MRSA infection by inhibiting the expression of the hemolysin of MRSA, which may provide experimental evidence for its development to a potential anti-MRSA drug.
Source: World Journal of Microbiology and Biotechnology - Category: Microbiology Source Type: research